Please wait a moment . . .

 

Medical Planning

Medical planning: A strategic approach to real-world evidence generation for successful medicine adoption

Our SWOT of new medicines provides a strategic approach to real-world evidence generation, by identifying the strengths and weaknesses of a medicine in a clinical practice setting as well as the opportunities for and threats to its success as a front-line treatment of choice.

We turn the results into an actionable strategy that provides more value than a traditional SWOT by establishing a pathway to success.

Working with your multidisciplinary team, we identify critical success factors and develop them into aspirational statements, key claims about your medicine that will support its success as it moves through the four key stakeholders of medicine adoption: the regulator, payor, prescriber, and patient.

https://medialis.co.uk/wp-content/uploads/2022/05/Asset-6.png

Identifying the data that makes a difference in medical affairs

Within 4-8 weeks, you will have suggestions for 30-50 publications, which will generate the real-world evidence necessary to support the claims you want to make, ensuring that you collect the data that makes a difference, right from the start.

Throughout this process, you will have access to our expert knowledge on real-world evidence generation for medicine adoption, supported by many original research publications on the topic.

Additionally, we’ll use our own innovative method for observing proportional group awareness and consensus, the Jandhyala method, to gain deeper insights from your team than are possible with traditional consensus methods.

From medical planning to real-world evidence generation

Many clients go on to use our real-world evidence generation services, benefiting from our years of experience in contract research and medical affairs. Our unique approach, the four pillars of real-world evidence generation, delivers gold standard construct measures and novel applications of expert opinion to fulfil stakeholder needs throughout medicine adoption, from regulator to patient.

Connect, follow and have a conversation with us

Medialis is a medical affairs consultancy servicing the pharmaceutical industry. Unlike some other agencies, we are proactive, not reactive or one-dimensional - if you need it, we can do it.

Medialis is a medical affairs consultancy servicing the pharmaceutical industry. Unlike some other agencies, we are proactive, not reactive or one-dimensional – if you need it, we can do it.